Back to
BALYASNY ASSET MANAGEMENT L.P.
GENB1 quarters
Position history for
BALYASNY ASSET MANAGEMENT L.P.'s holdings in GENERATE BIOMEDICINES INC
BALYASNY ASSET MANAGEMENT L.P. holds 79,489 shares of GENB (GENERATE BIOMEDICINES INC), worth $993,613 as of 2026-Q1. This is a new position. GENB represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.
Current Value
$993,613
Current Shares
79,489
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of GENB: FMR LLC, Capital World Investors, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP